Clinical Outcomes of a 3-day Benzodiazepine Detoxification Protocol With Continuous Subcutaneous Flumazenil Infusion: An Open-label Pilot Study.
- DOI
- 10.1097/adm.0000000000001786
- Published
- 2026 Sep 25
- Container
- Journal of addiction medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/adm.0000000000001786,
title = {Clinical Outcomes of a 3-day Benzodiazepine Detoxification Protocol With Continuous Subcutaneous Flumazenil Infusion: An Open-label Pilot Study.},
author = {Visser DA and Paling EP and Everaerd DS and van Alfen N and Zinkstok JR and Tendolkar I and Kramers C and Schellekens AFA},
year = {2026},
journal = {Journal of addiction medicine},
doi = {10.1097/adm.0000000000001786},
url = {https://doi.org/10.1097/adm.0000000000001786}
}RIS
TY - JOUR TI - Clinical Outcomes of a 3-day Benzodiazepine Detoxification Protocol With Continuous Subcutaneous Flumazenil Infusion: An Open-label Pilot Study. AU - Visser DA AU - Paling EP AU - Everaerd DS AU - van Alfen N AU - Zinkstok JR AU - Tendolkar I AU - Kramers C AU - Schellekens AFA PY - 2026 JO - Journal of addiction medicine DO - 10.1097/adm.0000000000001786 UR - https://doi.org/10.1097/adm.0000000000001786 ER -
APA
DA, V., EP, P., DS, E., N, V. A., JR, Z., I, T., C, K., & AFA, S. (2026). Clinical Outcomes of a 3-day Benzodiazepine Detoxification Protocol With Continuous Subcutaneous Flumazenil Infusion: An Open-label Pilot Study.. Journal of addiction medicine. https://doi.org/10.1097/adm.0000000000001786
Source records
- pubmed · retrieved 2026-09-26T15:25:51.703Z